Bridget E. Bunner

Array ( [id] => 7180467 [patent_doc_number] => 20050124543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Heterologous polypeptide of the TNF family' [patent_app_type] => utility [patent_app_number] => 11/048669 [patent_app_country] => US [patent_app_date] => 2005-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10360 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124543.pdf [firstpage_image] =>[orig_patent_app_number] => 11048669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7232729 [patent_doc_number] => 20050256036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Gastrointestinal proliferative factor and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/046644 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 108 [patent_figures_cnt] => 108 [patent_no_of_words] => 69482 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256036.pdf [firstpage_image] =>[orig_patent_app_number] => 11046644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7232827 [patent_doc_number] => 20050256044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Gastrointestinal proliferative factor and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/046456 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 108 [patent_figures_cnt] => 108 [patent_no_of_words] => 69532 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256044.pdf [firstpage_image] =>[orig_patent_app_number] => 11046456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7040292 [patent_doc_number] => 20050159336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy' [patent_app_type] => utility [patent_app_number] => 11/034262 [patent_app_country] => US [patent_app_date] => 2005-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 24303 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20050159336.pdf [firstpage_image] =>[orig_patent_app_number] => 11034262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7038853 [patent_doc_number] => 20050158287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Methods for using the obese gene and its gene product to identify hematopoietic progenitor cells' [patent_app_type] => utility [patent_app_number] => 11/026133 [patent_app_country] => US [patent_app_date] => 2004-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 15415 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20050158287.pdf [firstpage_image] =>[orig_patent_app_number] => 11026133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 853113 [patent_doc_number] => 07378498 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-27 [patent_title] => 'Protein encoded by a nucleic acid' [patent_app_type] => utility [patent_app_number] => 11/008889 [patent_app_country] => US [patent_app_date] => 2004-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 63 [patent_no_of_words] => 36127 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/378/07378498.pdf [firstpage_image] =>[orig_patent_app_number] => 11008889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7055611 [patent_doc_number] => 20050276784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Ligand for the c-kit receptor and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/988476 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 34566 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20050276784.pdf [firstpage_image] =>[orig_patent_app_number] => 10988476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823045 [patent_doc_number] => 20080227716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Use of Peptides for Protecting Skin from Hair-Treatment Agents' [patent_app_type] => utility [patent_app_number] => 10/580744 [patent_app_country] => US [patent_app_date] => 2004-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4247 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227716.pdf [firstpage_image] =>[orig_patent_app_number] => 10580744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 584673 [patent_doc_number] => 07438902 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Stem cells and their use in transplantation' [patent_app_type] => utility [patent_app_number] => 10/984645 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 31 [patent_no_of_words] => 18981 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/438/07438902.pdf [firstpage_image] =>[orig_patent_app_number] => 10984645 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7097844 [patent_doc_number] => 20050130303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Stimulation of hematopoiesis by ex vivo activated immune cells' [patent_app_type] => utility [patent_app_number] => 10/984183 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8806 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130303.pdf [firstpage_image] =>[orig_patent_app_number] => 10984183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6966026 [patent_doc_number] => 20050232923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Methods and compositions for treating MCP-1 related pathologies' [patent_app_type] => utility [patent_app_number] => 10/981936 [patent_app_country] => US [patent_app_date] => 2004-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37727 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232923.pdf [firstpage_image] =>[orig_patent_app_number] => 10981936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 923169 [patent_doc_number] => 07319141 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-15 [patent_title] => 'Stem cell growth factor-like polypeptides' [patent_app_type] => utility [patent_app_number] => 10/968674 [patent_app_country] => US [patent_app_date] => 2004-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 66969 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/319/07319141.pdf [firstpage_image] =>[orig_patent_app_number] => 10968674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5247803 [patent_doc_number] => 20070244037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Human Chemokine HCC-1 Polypeptides To Improve Stem Cell Transplantation' [patent_app_type] => utility [patent_app_number] => 10/577053 [patent_app_country] => US [patent_app_date] => 2004-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4668 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0244/20070244037.pdf [firstpage_image] =>[orig_patent_app_number] => 10577053 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9183421 [patent_doc_number] => 08623353 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-01-07 [patent_title] => 'TLR2 antagonistic antibody and use thereof' [patent_app_type] => utility [patent_app_number] => 10/595204 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 11968 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10595204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6938542 [patent_doc_number] => 20050112105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Compositions and treatments for myelosuppression by ex vivo activated immune cells' [patent_app_type] => utility [patent_app_number] => 10/939168 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15359 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112105.pdf [firstpage_image] =>[orig_patent_app_number] => 10939168 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 806409 [patent_doc_number] => 07419662 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-02 [patent_title] => 'Methods of making chemokine alpha 3 antibodies' [patent_app_type] => utility [patent_app_number] => 10/935306 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 19946 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/419/07419662.pdf [firstpage_image] =>[orig_patent_app_number] => 10935306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 359431 [patent_doc_number] => 07485310 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-03 [patent_title] => 'Use of CXCL6 chemokine in the prevention or repair of cartilage defects' [patent_app_type] => utility [patent_app_number] => 10/595072 [patent_app_country] => US [patent_app_date] => 2004-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 8811 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485310.pdf [firstpage_image] =>[orig_patent_app_number] => 10595072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7061127 [patent_doc_number] => 20050003488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Polypeptide, cDNA encoding the same, and use of them' [patent_app_type] => utility [patent_app_number] => 10/902777 [patent_app_country] => US [patent_app_date] => 2004-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9703 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003488.pdf [firstpage_image] =>[orig_patent_app_number] => 10902777 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5068923 [patent_doc_number] => 20070190024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Il-11 muteins' [patent_app_type] => utility [patent_app_number] => 10/565626 [patent_app_country] => US [patent_app_date] => 2004-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 18270 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190024.pdf [firstpage_image] =>[orig_patent_app_number] => 10565626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8151943 [patent_doc_number] => 08168429 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-01 [patent_title] => 'Method of amplifying hematopoietic stem cell and hematopoietic progenitor cell' [patent_app_type] => utility [patent_app_number] => 10/587014 [patent_app_country] => US [patent_app_date] => 2004-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10357 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/168/08168429.pdf [firstpage_image] =>[orig_patent_app_number] => 10587014 [rel_patent_id] =>[rel_patent_doc_number] =>)